Primary therapy of testicular tumors and prognostic factors of non-seminomatous germ cell tumors in clinical stage I;Primärtherapie des hodentumors und prognosefaktoren nichtseminomatöser keimzelltumoren im klinischen stadium I

Onkologe

Volumn 9, Issue 9, 2003, Pages 968-972

  Heidenreich, A ^a   Albers, P ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT; LACTATE DEHYDROGENASE;

CANCER CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; TESTIS TUMOR; TUMOR BIOPSY;

EID: 0141557591     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00761-003-0556-4     Document Type: Review

References (20)

1. Albers P, Siener R, Kliesch S, Weissbach L, Krege S, Sparwasser C, Schulze H, Heidenreich A, de Riese W, Loy V, Bierhoff E, Wittekind C, Hartmann M (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group. J Clin Oncol 21:1505-1512
2. Albers P, Ulbright TM, Albers J, Miller GA, Orazi A, Crabtree WN, Baniel J, Reister J, Sidner RA, Foster RS, Donohue JP (1996) Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. J Urol 155:579-586
3. Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N, Müller SC (1997) MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 79:1710-1716
4. Capelouto CC, Clark PE, Ransil BJ, Loughlin KR (1995) A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol 153:981-985
5. Dieckmann KP, Skakkebaeck NE (1999) Carcinoma in situ of the testis: a review of biological and clinical features. Int J Cancer 83:815-823
6. Dieckmann KP, Loy V (2003) False-negative biopsies for the diagnosis of testicular intraepithelial neoplasia (TIN)-an update. Eur Urol 43:516-521
7. Elert A, Olbert P, Hegele A, Barth P, Hofmann R, Heidenreich A (2002) Accuracy of frozen section examination of testicular tumors of uncertain origin. Eur Urol 41:290-293
8. Heidenreich A, Albers P, Hartmann M, Kliesch S, Köhrmann KU, Krege S, Lossin P, Weissbach L for the German Testicular Cancer Study Group (2003) Complications of primary nerve-sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169:1710-714
9. Heidenreich A (2002) Clinical stage I nonseminomatous testicular germ-cell tumors: surgery or watchful waiting? Curr Opin Urol 12:427-430
10. Heidenreich A, Moul JW (2002) Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? Sem Urol Oncol 20:234-238
11. Heidenreich A, Weißbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, Dieckmann KP for the German Testicular Cancer Study Group (2001) Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 166:2161-2165
12. Heidenreich A, Sesterhenn IA, Mostofi FK, Srivastava S, Moul JW (1998) Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk for metastasis. Cancer 83:1002-1011
13. Herr HW, Sheinfeld J (1997) Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 158:1331-1334
14. Kliesch S, Thomaidis T, Schütte B, Pühse G, Kater B, Roth S, Bergmann M (2003) Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 111:70-75
15. Krege S, Schmoll HJ, Souchon R (2001) Interdisziplinärer Konsensus zur Diagnostik und Therapie von Hodentumoren. Ergebnisse einer Update-Konferenz auf Grundlage evidenz-basierter Medizin (EBM). Urol A 40:137-147
16. Leibovitch I, Baniel J, Foster RS, Donohue JP (1995) The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer. J Urol 154:935-939
17. Oliver RTD, Ong J, Berney D, Nargund V, Bedenoch D, Shamash J (2003) Testis conserving chemotherapy in germ cell cancer: its potential to increaseunderstanding of the biology and treatment of carcinoma-in-situ. APMIS 111:86-92
18. Petersen PM, Giwercman A, Daugaard G, Rorth M, Petersen JH, Skakkebaek NE, Hansen SW, von der Maase H (2002) Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ of the testis. J Clin Oncol 20:1537-1543
19. Read G, Stenning SP, Cullen MH, Hrowich A, Kaye SB, Cook PA (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10:1762-1768
20. Sedlmayer F, Höltl W, Kozak W, Hawliczek R, Gebhart F, Gerber E, Joos H, Albrecht W, Pummer K, Kogelnik HD (2001) Radiotherapy of testicular intraepithelial neoplasia (TIN): a novel treatment regimen for a rare disease. Int J Radiat Oncol Biol Phys 50:909-913